Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGIR | P43119 | 7/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 6/20 | 0.40 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7730002 | 0.87 | PTGIR (0.55) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7739724 | 0.82 | PTGIR (0.54) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7737492 | 0.81 | PTGIR (0.51) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7730063 | 0.80 | PTGIR (0.55) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7736488 | 0.78 | PTGIR (0.54) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7730025 | 0.77 | PTGIR (0.54) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7739676 | 0.73 | PTGIR (0.55) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7730030 | 0.72 | PTGIR (0.56) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7736529 | 0.72 | PTGIR (0.56) | PTGIRTBXA2RCYSLTR2CYSLTR1 | |
| SCHEMBL7736580 | 0.72 | PTGIR (0.48) | PTGIRTBXA2RKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9381243-B2 | Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof | RIGSHOSPITALET (DK) | 2016-07-05 | — | — | US | claimed |
| US-20150057325-A1 | COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST | RIGSHOSPITALET (DK) | 2015-02-26 | — | — | US | claimed |
| US-8877710-B2 | Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof | RIGHOSPITALET (DK) | 2014-11-04 | — | — | US | claimed |
| US-20140322207-A1 | METHODS OF IDENTIFYING CRITICALLY ILL PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ORGAN FAILURE AND COMPOUNDS FOR THE TREATMENT HEREOF | ENDOTHEL PHARMA APS (DK) | 2014-10-30 | — | — | US | claimed |
| EP-2699243-A1 | PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE | Rigshospitalet (DK) | 2014-02-26 | — | — | EP | claimed |
| US-20140044797-A1 | PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE | RIGSHOSPITALET (DK) | 2014-02-13 | — | — | US | claimed |
| US-20130261177-A1 | COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST | RIGSHOSPITALET (DK) | 2013-10-03 | — | — | US | claimed |
| EP-2622354-A1 | COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST | Rigshospitalet (DK) | 2013-08-07 | — | — | EP | claimed |
| EP-2563369-A2 | METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF | Thrombologic APS (DK) | 2013-03-06 | — | — | EP | claimed |
| US-20130040898-A1 | METHODS OF TREATMENT OF PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ISCHEMIC EVENTS AND COMPOUNDS HEREOF | THROMBOLOGIC APS (DK) | 2013-02-14 | — | — | US | claimed |
| WO-2012143012-A1 | PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE | RIGSHOSPITALET (DK) | 2012-10-26 | — | — | WO | claimed |
| WO-2012041334-A1 | COMPOUNDS CAPABLE OF MODULATING/PRESERVING ENDOTHELIAL INTEGRITY FOR USE IN PREVENTION OR TREATMENT OF ACUTE TRAUMATIC COAGULOPATHY AND RESUSCITATED CARDIAC ARREST | RIGSHOSPITALET (DK) | 2012-04-05 | — | — | WO | claimed |
| US-20110268732-A1 | METHODS OF IDENTIFYING CRITICALLY ILL PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ORGAN FAILURE AND COMPOUNDS FOR THE TREATMENT HEREOF | THROMBOLOGIC APS (DK) | 2011-11-03 | — | — | US | claimed |
| WO-2010075861-A2 | METHODS OF IDENTIFYING CRITICALLY ILL PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ORGAN FAILURE AND COMPOUNDS FOR THE TREATMENT HEREOF | THROMBOLOGIC APS (DK) | 2010-07-08 | — | — | WO | claimed |
| US-9872864-B2 | Sustained release composition of prostacyclin | ASCENDIS PHARMA A/S (DK) | 2018-01-23 | — | — | US | disclosed |
| EP-2384196-B1 | METHODS OF IDENTIFYING CRITICALLY ILL PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ORGAN FAILURE AND COMPOUNDS FOR THE TREATMENT HEREOF | JOHANSSON PÄR (SE) | 2017-09-13 | — | — | EP | disclosed |
| US-9381243-B2 | Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof | RIGSHOSPITALET (DK) | 2016-07-05 | — | — | US | disclosed |
| WO-2012143012-A1 | PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE | RIGSHOSPITALET (DK) | 2012-10-26 | — | — | WO | disclosed |
| US-20110268732-A1 | METHODS OF IDENTIFYING CRITICALLY ILL PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ORGAN FAILURE AND COMPOUNDS FOR THE TREATMENT HEREOF | THROMBOLOGIC APS (DK) | 2011-11-03 | — | — | US | disclosed |
| WO-2010075861-A2 | METHODS OF IDENTIFYING CRITICALLY ILL PATIENTS AT INCREASED RISK OF DEVELOPMENT OF ORGAN FAILURE AND COMPOUNDS FOR THE TREATMENT HEREOF | THROMBOLOGIC APS (DK) | 2010-07-08 | — | — | WO | disclosed |